Related Experiment Videos
Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial
Hideki Sakaguchi1, Jiro Fujimoto, Bao Li Hong
1Department of Obstetrics and Gynecology, Gifu University School of Medicine, Gifu City, 500-8705, Japan. hideki-s@cc.gifu-u.ac.jp
Gynecologic Oncology
|April 22, 2004
Summary
High progesterone receptor B (PR-B) mRNA levels, but not PR-A, correlate with improved survival in endometrial cancer (EC). PR isoform measurement offers prognostic value for EC patients.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Progesterone receptor (PR) is crucial for endocrine treatment success and prognosis in endometrial cancer (EC).
- Understanding the distinct roles of PR isoforms, PR-A and PR-B, is essential for EC management.
Purpose of the Study:
- To investigate the clinical implications of PR-A and PR-B expression in EC.
- To determine the prognostic significance of PR isoforms in endometrial cancer.
Main Methods:
- Quantified mRNA levels of total PR (PR-AB) and PR-B using real-time RT-PCR in 120 EC and 40 normal endometria.
- Analyzed correlations between PR isoform expression and clinical characteristics (stage, grade, invasion) and patient prognosis.
Main Results:
- PR-B mRNA levels, unlike PR-A, significantly correlated with patient survival, independent of clinical factors.
- The ratio of PR-B to total PR (B/AB) was significantly lower in deceased EC cases compared to surviving cases and normal endometria.
Conclusions:
- PR-B likely possesses distinct functions from PR-A in EC.
- Disrupted PR isoform expression is associated with poor prognosis in EC.
- Measuring PR isoforms provides valuable prognostic information for endometrial cancer.